Orchestra BioMed Holdings annual return on equity
2022
2023
2024
2025
Orchestra BioMed Holdings Return on Equity (ROE) Growth & History (OBIO)
Orchestra BioMed Holdings's return on equity was −121.81% for fiscal 2025.
View full Orchestra BioMed Holdings company overviewOrchestra BioMed Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −121.81% | −0.97 pp |
| 2024 | 2024-12-31 | −120.84% | −39.36 pp |
| 2023 | 2023-12-31 | −81.47% | +123.73 pp |
| 2022 | 2022-12-31 | −205.21% | — |
Orchestra BioMed Holdings quarterly return on equity
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −78.51% | +147.27 pp |
| Q1 2026 | 2026-03-31 | −43.67% | +31.63 pp |
| Q4 2025 | 2025-12-31 | 12.84% | +53.64 pp |
| Q3 2025 | 2025-09-30 | −94.60% | −60.45 pp |
| Q2 2025 | 2025-06-30 | −225.78% | −194.24 pp |
| Q1 2025 | 2025-03-31 | −75.30% | −53.80 pp |
| Q4 2024 | 2024-12-31 | −40.81% | −23.45 pp |
| Q3 2024 | 2024-09-30 | −34.15% | −18.40 pp |
| Q2 2024 | 2024-06-30 | −31.55% | −18.81 pp |
| Q1 2024 | 2024-03-31 | −21.50% | −7.13 pp |
| Q4 2023 | 2023-12-31 | −17.36% | +24.61 pp |
| Q3 2023 | 2023-09-30 | −15.75% | — |
| Q2 2023 | 2023-06-30 | −12.73% | — |
| Q1 2023 | 2023-03-31 | −14.37% | — |
| Q4 2022 | 2022-12-31 | −41.97% | — |
Orchestra BioMed Holdings return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Orchestra BioMed Holdings's return on equity increased from −205.21% to −121.81%, a change of +83.40 percentage points. The latest reported quarter, Q2 2026, shows −78.51%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Orchestra BioMed Holdings source filings ↗